The Romanian anti-Covid 19 vaccine seems to have reached a deadlock concerning the funds needed for ongoing research. The initially allocated amount is insufficient, and the making of the vaccine needs financing, says university professor Ph. D. Virgil Păunescu, coordinator of the Decode project (for the making of the Romanian anti-Covid 19 vaccine). According to him, 5 more million Euros would be needed to move to the testing phase. The specialist recently announced on his Facebook page: 'Thanks to the efforts of our team, the OncoGen center is in negotiations with the European Bank of Investments (EIB) for financing the manufacturing facilities for Sars-Cov-2 vaccines in Romania.
